ISRCTN35543977已完成未知
The efficacy and safety of anlotinib (AL3818) treatment in patients with advanced non-small cell lung cancer in the real world
Peking University Shenzhen Hospital0 个研究点目标入组 203 人开始时间: 2021年1月26日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 203
研究概览
简要总结
2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34357411/ (added 09/08/2021)
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. Age =8 years
- •2. Pathologically confirmed stage IIIB/IV or recurrent NSCLC
- •3. Had at least one radiologically measurable disease as assessed using Response Evaluation Criteria in Solid Tumours (RECIST, version 1.1); and they did not receive local treatment such as radiotherapy or interventional therapy for the target lesions during anlotinib treatment
排除标准
- •1. Other pathological types than NSCLC including small cell lung cancer (including mixed with small cell and non-small cell lung cancer)
- •2. Patients who are diagnosed with malignancies other than NSCLC within the previous 5 years (except those with negligible risk of metastases or death and treated with curative intent, based on primary investigator discretion)
研究者
相似试验
进行中（未招募）
1 期
Evaluation of AL3818 in Combination With Nivolumab in Solid TumorsSolid Tumor, AdultSoft Tissue SarcomaNon Small Cell Lung CancerSmall Cell Lung CancerNCT04165330Sarcoma Oncology Research Center, LLC56
Unknown
2 期
A Trial of Anlotinib Combined With Docetaxel in Patients With Wild-type Advanced Non-squamous Non Small Cell Lung CancerNon Small Cell Lung CancerNCT04619537Shandong Cancer Hospital and Institute42
已完成
1 期
Anlotinib Hydrochloride Combined With AP in Stage IIIB/IIIC/IV Non-squamous Non-small-cell Lung CancerNon-squamous Non-small-cell Lung CancerAnlotinibNCT04012619Sichuan University8
招募中
2 期
Anlotinib Plus Toripalimab as First-line Treatment for Advanced Gastric Cancer With ECOG 2 (APICAL-GC)ImmunotherapyAnlotinibToripalimabGastric CancerNCT04278222Shanghai Changzheng Hospital24
Unknown
2 期
Anlotinib or Penpulimab in Combination With RAI for DTCThyroid CancerNCT04952493Peking Union Medical College Hospital42